321 related articles for article (PubMed ID: 35174539)
1. Validation of five hepatic steatosis algorithms in metabolic-associated fatty liver disease: A population based study.
Liu Y; Liu S; Huang J; Zhu Y; Lin S
J Gastroenterol Hepatol; 2022 May; 37(5):938-945. PubMed ID: 35174539
[TBL] [Abstract][Full Text] [Related]
2. Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD.
Chen J; Mao X; Deng M; Luo G
Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):394-401. PubMed ID: 36695773
[TBL] [Abstract][Full Text] [Related]
3. Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang.
Guo Y; Hu Y; Yang J; Ma R; Zhang X; Guo H; Wang X; Li Y; Peng X; Zhang S; He J; Guo S
Eur J Med Res; 2023 Dec; 28(1):555. PubMed ID: 38042816
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease.
Han AL; Lee HK
Metabolites; 2022 Jul; 12(7):. PubMed ID: 35888788
[TBL] [Abstract][Full Text] [Related]
5. Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scores.
Capela TL; Silva VM; Freitas M; Arieira C; Gonçalves TC; de Castro FD; Magalhães J; Cotter J
BMC Gastroenterol; 2023 Dec; 23(1):437. PubMed ID: 38093213
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive Screening of Metabolic Associated Fatty Liver Disease and Affecting Factors in Primary Care.
Balci IC; Haciagaoglu N; Oner C; Cetin H; Simsek EE
J Coll Physicians Surg Pak; 2023 Apr; 33(4):390-395. PubMed ID: 37190709
[TBL] [Abstract][Full Text] [Related]
7. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.
Sviklāne L; Olmane E; Dzērve Z; Kupčs K; Pīrāgs V; Sokolovska J
J Gastroenterol Hepatol; 2018 Jan; 33(1):270-276. PubMed ID: 28464337
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic ability using fatty liver and metabolic markers for metabolic-associated fatty liver disease stratified by metabolic/glycemic abnormalities.
Okada A; Yamada G; Kimura T; Hagiwara Y; Yamaguchi S; Kurakawa KI; Nangaku M; Yamauchi T; Matsuyama Y; Kadowaki T
J Diabetes Investig; 2023 Mar; 14(3):463-478. PubMed ID: 36566480
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease.
Zou H; Ma X; Zhang F; Xie Y
Lipids Health Dis; 2023 Sep; 22(1):145. PubMed ID: 37674196
[TBL] [Abstract][Full Text] [Related]
11. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
[TBL] [Abstract][Full Text] [Related]
12. Population-specific cut-off points of fatty liver index: a study based on the National Health and Nutrition Examination Survey data.
Wu J; Tian S; Li H; Xu Z; Li S; Chen YL; Liang XY; Xiao J; Song JY; She RL; Ma CY; Feng JH; Li ZX; Jiang ZY; Zhang ZW; Wu KN; Kong LQ
BMC Gastroenterol; 2022 May; 22(1):265. PubMed ID: 35624410
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.
Zelber-Sagi S; Webb M; Assy N; Blendis L; Yeshua H; Leshno M; Ratziu V; Halpern Z; Oren R; Santo E
World J Gastroenterol; 2013 Jan; 19(1):57-64. PubMed ID: 23326163
[TBL] [Abstract][Full Text] [Related]
14. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults.
Peng H; Pan L; Ran S; Wang M; Huang S; Zhao M; Cao Z; Yao Z; Xu L; Yang Q; Lv W
Front Endocrinol (Lausanne); 2023; 14():1083032. PubMed ID: 36742412
[TBL] [Abstract][Full Text] [Related]
15. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.
Otsubo N; Fukuda T; Cho G; Ishibashi F; Yamada T; Monzen K
Intern Med; 2023 Aug; 62(16):2307-2319. PubMed ID: 36517035
[TBL] [Abstract][Full Text] [Related]
16. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.
Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A
Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768
[TBL] [Abstract][Full Text] [Related]
17. Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease.
Han AL
Diabetol Metab Syndr; 2022 Mar; 14(1):44. PubMed ID: 35317824
[TBL] [Abstract][Full Text] [Related]
18. Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population.
Cai J; Lin C; Lai S; Liu Y; Liang M; Qin Y; Liang X; Tan A; Gao Y; Lu Z; Wu C; Huang S; Yang X; Zhang H; Kuang J; Mo Z
Lipids Health Dis; 2021 Oct; 20(1):145. PubMed ID: 34706716
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of Insulin Resistance- and Steatosis-Based Scores in Monitoring Metabolic Associated Fatty Liver Disease Treatment Response.
Ye J; Lin Y; Shao C; Sun Y; Feng S; Zhong B
Ann Nutr Metab; 2023; 79(5):448-459. PubMed ID: 37678173
[TBL] [Abstract][Full Text] [Related]
20. [Applied research of ultrasound attenuation parameter in the diagnosis of metabolic dysfunction-associated fatty liver disease].
Hou MM; Yuan XW; Wang YQ; Zhang Y; Zhang SY; Yu SH; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):290-296. PubMed ID: 35462485
[No Abstract] [Full Text] [Related]
[Next] [New Search]